World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
110
Citations
40896
World Ranking
507
National Ranking
307

Medicine

D-Index
110
Citations
40911
World Ranking
5601
National Ranking
3012

Eva Harris publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Eva Harris sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 394 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Eva Harris D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Eva Harris sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 110 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1999 - Hellman Fellow
  • 1997 - Fellow of the MacArthur Foundation

Overview

Eva Harris is affiliated with the University of California, Berkeley in the United States. Their research primarily spans the field of Medicine with a focus on Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Modeling and Simulation, and Molecular Biology.

The scientist's work covers several main topics including:

  • Mosquito-borne diseases and control
  • Viral Infections and Vectors
  • Malaria Research and Control
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 epidemiological studies
  • Viral Infections and Outbreaks Research
  • Virology and Viral Diseases

Recent publications by Eva Harris include:

  • "Zika virus infection enhances future risk of severe dengue disease," 2020, Science
  • "Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction," 2021, Science
  • "Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection," 2022, Nature Genetics
  • "Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses," 2022, Nature Immunology
  • "Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination," 2022, Nature Immunology

Frequent co-authors collaborating with Eva Harris include Ángel Balmaseda, Guillermina Kuan, Aubree Gordon, Scott B. Biering, and José Víctor Zambrana.

The scientist publishes regularly in venues such as bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, Journal of Virology, PLoS Neglected Tropical Diseases, and Nature Communications.

Eva Harris has also contributed to book publications, including a title published by Cambridge University Press: "Migration" (2020).

Awards received by Eva Harris include the Hellman Fellow award in 1999 and a fellowship from the MacArthur Foundation in 1997.

Best Publications

  • Dengue

    Unknown

  • Antibody-dependent enhancement of severe dengue disease in humans

    Leah C. Katzelnick;Lionel Gresh;M. Elizabeth Halloran;M. Elizabeth Halloran;Juan Carlos Mercado

  • Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis

    Harish Nair;Harish Nair;W Abdullah Brooks;Mark Katz;Anna Roca

  • Global spread and persistence of dengue.

    Jennifer L. Kyle;Eva Harris

  • Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

    Karin Stettler;Martina Beltramello;Diego A. Espinosa;Victoria Graham

  • The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

    Martina Beltramello;Katherine L. Williams;Cameron P. Simmons;Annalisa Macagno

  • Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis

    Karen Clyde;Jennifer L. Kyle;Eva Harris

  • Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus

    William B. Messer;Duane J. Gubler;Eva Harris;Kamalanayani Sivananthan

  • Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination

    P. Robert Beatty;Henry Puerta-Guardo;Sarah S. Killingbeck;Dustin R. Glasner

  • The WHO dengue classification and case definitions: time for a reassessment.

    Jacqueline L Deen;Eva Harris;Bridget Wills;Angel Balmaseda

  • Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission.

    Takako Tabata;Matthew Petitt;Henry Puerta-Guardo;Daniela Michlmayr

  • Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification

    Scott J. Balsitis;Katherine L. Williams;Ruben Lachica;Diana Flores

  • Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua.

    Samantha Nadia Hammond;Angel Balmaseda;Leonel Pérez;Yolanda Tellez

  • Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons

    Michael S. Diamond;Michael S. Diamond;T. Guy Roberts;Dianna Edgil;Betty Lu

  • Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness

    Gayathri Manokaran;Esteban Finol;Esteban Finol;Chunling Wang;Jayantha Gunaratne;Jayantha Gunaratne

  • Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

    Sujan Shresta;Kristin L. Sharar;Daniil M. Prigozhin;P. Robert Beatty

  • Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR

    Eva Harris;T. Guy Roberts;Leila Smith;John Selle

  • Serotype-specific differences in clinical manifestations of dengue.

    Angel Balmaseda;Samantha N. Hammond;Leonel Pérez;Yolanda Tellez

  • Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus

    Jesse Waggoner;Lionel Gresh;Maria Jose Jose Vargas;Gabriela Ballesteros

  • Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua.

    Eva Harris;Elsa Videa;Leonel Perez;Erick Sandoval

  • Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical

    Sujan Shresta;Jennifer L. Kyle;Heidi M. Snider;Manasa Basavapatna

Frequent Co-Authors

Angel Balmaseda
Angel Balmaseda University of California, Berkeley
Neil Andersson
Neil Andersson McGill University
Aravinda M. de Silva
Aravinda M. de Silva University of North Carolina at Chapel Hill
Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Daniela Weiskopf
Daniela Weiskopf La Jolla Institute For Allergy & Immunology
Sergio R. Ojeda
Sergio R. Ojeda Oregon National Primate Research Center
Anna P. Durbin
Anna P. Durbin Johns Hopkins University
Benjamin A. Pinsky
Benjamin A. Pinsky Stanford University
Cameron P. Simmons
Cameron P. Simmons University College London
Laura D. Kramer
Laura D. Kramer University at Albany, State University of New York

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse healthcare and research careers, many of which benefit from complementary nursing qualifications. For professionals aiming to enhance their clinical expertise, exploring an fnp to acute care np bridge program can be an effective way to transition into specialized acute care roles. These bridge programs build upon Family Nurse Practitioner experience, aligning well with immunology-focused patient care.

For those new to nursing but interested in a faster route to becoming a nurse practitioner, an accelerated fnp program offers an efficient pathway to enter the field with advanced qualifications. Such programs are designed for speed without compromising on quality, catering to students passionate about immunology and patient wellness.

Non-nurses considering a career shift can explore the best online rn programs for non nurses. These programs provide foundational nursing knowledge essential for clinical roles connected to immunology research or treatment.

Additionally, individuals seeking accessible entry points into nursing may find numerous absn programs with high acceptance rates. These accelerated Bachelor of Science in Nursing degrees offer a practical and attainable way to launch a nursing career, complementing studies in immunology with hands-on healthcare experience.

Best Scientists Citing Eva Harris

Trending Scientists

Recently Published Articles